Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer

Published:2016-10-15 Issue:4 Volume:48 Page:1338-1350
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Kim Ji-Yeon,Park Kyunghee,Jung Hae Hyun,Lee Eunjin,Cho Eun Yoon,Lee Kwang Hee,Bae Soo Youn,Lee Se Kyung,Kim Seok Won,Lee Jeong Eon,Nam Seok Jin,Ahn Jin Seok,Im Young-Hyuck,Park Yeon Hee

Funder

Samsung Biomedical Research Institute

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://e-crt.org/upload/pdf/crt-2015-430.pdf

Reference28 articles.

1. p53 and Human Cancer: The First Ten Thousand Mutations

2. p53, the Cellular Gatekeeper for Growth and Division

3. Surfing the p53 network

4. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of microRNA-141-3p, E2F3, CDK3, and KAT2B overexpression on histologic tumor grade and metastasis status in untreated breast cancer tissues;BioImpacts;2024-06-23

2. TP53 and/or BRCA1 Mutations Based on CtDNA Analysis as Prognostic Biomarkers for Primary Triple-Negative Breast Cancer;Cancers;2024-03-18

3. TP53R175H mutation promotes breast cancer cell proliferation through CORO1A–P38 MAPK pathway regulation;Biochemical Pharmacology;2024-03

4. Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice;Medicina;2024-01-17

5. Building a genetic and epigenetic predictive model of breast cancer intrinsic subtypes using large-scale data and hierarchical structure learning;2023-06-13